Bibliografía

 consultada  sobre  diagnóstico  y  tratamiento  precoz  de  la  EPOC  

Mayo  de  2010  
 
1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. British medical journal.
1977;1(6077):1645.

2. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, SONIA BUIST A, et al. Smoking
cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung
Health Study. American journal of respiratory and critical care medicine. 2000;161(2):381.

3. Peña VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographic
Variations in Prevalence and Underdiagnosis of COPD*. Chest. 2000 Oct;118(4):981-989.

4. Pauwels. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive
pulmonary disease. N. Engl. J. Med. 2000 Dic 28;343(26):1902-1909.

5. Zieliñski J, Bednarek M. Early Detection of COPD in a High-Risk Population Using Spirometric

Screening*. Chest. 2001 Mar;119(3):731-736.

6. Chavannes N, Vollenberg JJH, Van Schayck CP, Wouters EFM. Effects of physical activity in mild
to moderate COPD: a systematic review. The British Journal of General Practice. 2002;52(480):574.

7. Highland KB, Strange C, Heffner JE. Long-term effects of inhaled corticosteroids on FEV1 in
patients with chronic obstructive pulmonary disease: A meta-analysis. Annals of internal medicine.
2003;138(12):969.

8. Schermer TR. Validity of spirometric testing in a general practice population of patients with
chronic obstructive pulmonary disease (COPD). Thorax. 2003 10;58(10):861-866.

9. Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J. Diagnosis of

Airflow Limitation Combined With Smoking Cessation Advice Increases Stop-Smoking Rate*.
Chest. 2003 Jun;123(6):1916-1923.

10. Ramsey SD, Sullivan SD. Chronic obstructive pulmonary disease: Is there a case for early
intervention? American Journal of Medicine Supplements. 2004;117(12S1):3–10.

11. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in
chronic obstructive pulmonary disease. American Journal of Clinical Nutrition. 2005;82(1):53.

12. Anthonisen. The Effects of a Smoking Cessation Program on Long-Term Survival in Smokers with
Mild Lung Disease. Annals of Internal Medicine. 2005 Feb 15;142(4).

13. Lindberg A, Bjerg-B\äcklund A, R\önmark E, Larsson LG, Lundb\äck B. Prevalence and

underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from
the Obstructive Lung Disease in Northern Sweden Studies. Respiratory medicine. 2006;100(2):264–
272.

14. Soler JJ, Mart\'ınez-Garc\'ıa MA, Román P, Orero R, Terrazas S, Mart\'ınez-Pechuán A. Eficacia de
 un programa específico para pacientes con EPOC que presentan frecuentes agudizaciones. Arch
Bronconeumol. 2006;42(10):501–508.

15. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in

patient reported outcomes in patients with COPD. Respiratory medicine. 2007;101(1):146–153.

16. Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, et al. The 6-min
walking distance: long-term follow up in patients with COPD. European Respiratory Journal. 2007
3;29(3):535-540.

17. Bellamy D, Smith J. Role of primary care in early diagnosis and effective management of COPD. Int
J Clinical Practice. 2007 8;61(8):1380-1389.

18. Johansson G, Lindberg A, Romberg K, Nordstr\öm L, Gerken F, Roquet A. Bronchodilator efficacy

of tiotropium in patients with mild to moderate COPD. Prim Care Respir J. 2008;17:169–75.

19. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung
age: the Step2quit randomised controlled trial. British Medical Journal. 2008;

20. Radin A, Cote C. Primary care of the patient with chronic obstructive pulmonary disease—part 1:
frontline prevention and early diagnosis. The American Journal of Medicine. 2008;121(7S1):3–12.

21. Ofir D, Laveneziana P, Webb KA, Lam Y, O'Donnell DE. Mechanisms of Dyspnea during Cycle
Exercise in Symptomatic Patients with GOLD Stage I Chronic Obstructive Pulmonary Disease.
American Journal of Respiratory and Critical Care Medicine. 2008 1;177(6):622-629.

22. Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Kalberg C, et al. PREVALENCE OF

COPD-DEFINED AIRFLOW OBSTRUCTION IN UNDIAGNOSED PRIMARY CARE
SUBJECTS WITH SYMPTOMS OF CHRONIC BRONCHITIS. Chest. 2008 Oct 1;134(4):p20001.

23. Castillo D, Guayta R, Giner J, Burgos F, Capdevila C, Soriano JB, et al. COPD case finding by
spirometry in high-risk customers of urban community pharmacies: A pilot study. Respiratory
Medicine. 2009;103(6):839–845.

24. Davies L, Calverley PM. UPLIFTing care for chronic obstructive pulmonary disease. The Lancet.
2009;374(9696):1129–1130.

25. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes
in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup
analysis of a randomised controlled trial. The Lancet. 2009;374(9696):1171–1178.

26. Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Mui\ no A, et al. Health
status perception and airflow obstruction in five Latin American cities: The PLATINO study.
Respiratory Medicine. 2009;103(9):1376–1382.

27. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary
disease. The Lancet. 2009;374(9691):721–732.
 28. Valdivia G, Pertuzé J, Moreno D, others, Montes de Oca M, Tálamo C, et al. Health status
perception and airflow obstruction in five Latin American cities: The PLATINO study. Respiratory
Medicine. 2009;103(9):1376–1382.

29. O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam Y, Ofir D. Evaluation of acute bronchodilator
reversibility in patients with symptoms of GOLD stage I COPD. Thorax. 2009 3;64(3):216-223.

30. de Oca MM, Talamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muino A, et al. Frequency of Self-
Reported COPD Exacerbation and Airflow Obstruction in Five Latin American Cities: The Proyecto
Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) Study. Chest. 2009
4;136(1):71-78.

31. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence
of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax.
2009 6;64(10):863-868.

32. Jing J, Huang T, Cui W, Xu F, Shen H. Should FEV1/FEV6 Replace FEV1/FVC Ratio To Detect
Airway Obstruction? Chest. 2009 Abr;135(4):991-998.